Chronic obstructive pulmonary disease (COPD) is a major cause of death among patients with renal cell carcinoma (RCC) in the United States, investigators reported at ASCO’s 2025 Genitourinary Cancers ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

Lifetime excess body weight and significant weight gain in adulthood are associated with an increased risk for renal cell ...

Excess weight in mid-life is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout life may also affect an individual’s likelihood of developing this ...

PD-32766 for patients with clear cell renal cell carcinoma (ccRCC) was conducted at the National Cancer Center Hospital East and promising results were obtained. PET positive rate: 64 Cu-PD-32766 was ...

The business announced the intermediary results from its prospective multi-centre trial designed to determine if ...

Hutchmed China, alongside Innovent Biologics, announced on Wednesday that the FRUSICA-2 phase two and three clinical trial ...

Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma ...

Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.